Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Vaccine|March 21, 2013
A serum-free, purified vero cell rabies vaccine is safe and as immunogenic as the reference vaccine Verorab for pre-exposure use in healthy adults: results from a randomized controlled phase-II trialSylvie Pichon, Françoise Guinet-Morlot, Maria Minutello, et al.
Vaccine|July 1, 2022
Safety and immunogenicity of a serum-free purified Vero rabies vaccine in healthy adults: A randomised phase II pre-exposure prophylaxis studySylvie Pichon, Annick Moureau, Celine Petit, et al.
Vaccine|October 24, 2013
A next-generation, serum-free, highly purified Vero cell rabies vaccine is safe and as immunogenic as the reference vaccine Verorab® when administered according to a post-exposure regimen in healthy children and adults in ChinaRongcheng Li, Lirong Huang, Jia Li, et al.
Biologicals : Journal of the International Association of Biological Standardization|May 21, 2019
Potency test to discriminate between differentially over-inactivated rabies vaccines: Agreement between the NIH assay and a G-protein based ELISAAudrey Toinon, Nadege Moreno, Heloise Chausse, et al.
Biologicals : Journal of the International Association of Biological Standardization|February 19, 2017
G-protein based ELISA as a potency test for rabies vaccinesMartine Chabaud-Riou, Nadège Moreno, Fabien Guinchard, et al.
Journal of Bacteriology|January 20, 2004
Transferrin-binding protein B of Neisseria meningitidis: sequence-based identification of the transferrin-Binding site confirmed by site-directed mutagenesisGeneviève Renauld-Mongénie, Laurence Lins, Tino Krell, et al.
Vaccine|August 3, 2025
Lentiviral vector-based T-cell vaccines against Zika and yellow fever virusesPierre Authié, Philippe Souque, Fanny Moncoq, et al.
Vaccine|January 14, 2017
Replacement of in vivo human rabies vaccine potency testing by in vitro glycoprotein quantification using ELISA - Results of an international collaborative studySylvie Morgeaux, Bertrand Poirier, C Ian Ragan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 13, 2024
Immunogenicity and Safety of a Purified Vero Rabies Vaccine-Serum Free, Compared With 2 Licensed Vaccines, in a Simulated Rabies Post-Exposure Regimen in Healthy Adults in France: A Randomized, Controlled, Phase 3 TrialAndrea-Clemencia Pineda-Peña, Qian Jiang, Celine Petit, et al.
Cell Reports|July 29, 2022
A lentiviral vector encoding fusion of light invariant chain and mycobacterial antigens induces protective CD4+ T cell immunityJodie Lopez, François Anna, Pierre Authié, et al.
Pageof 3